Prostate cancer: the role of transrectal ultrasound and its impact on cancer detection and management.
With the advent of higher-frequency transducers as well as Doppler technologies, TRUS has become a valuable tool in the detection and management of prostate cancer. When combined with the other risk identifiers, an informed patient, and an experienced operator, it cannot only reduce the number of missed cancers by effective targeting of biopsies, but also reduce the number of unnecessary biopsies.